ANI Pharmaceuticals Inc (ANIP NASDAQ) stock market data APIs
$80.8126
-2.36(-2.9%)
as of April 9, 2026
Try our APIs with
free plan!
ANI Pharmaceuticals Inc Financial Data Overview
Price chart is built with
Anychart
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Prev. Close
80.8126
Open
78.4523
High
81.5043
Low
78.3299
52 wk Range
56.71-99.5
Market Cap
1 800 M
P/E Ratio
24.1386
Shares Outstanding
22 414 K
Revenue
883 M
EPS
2.33
Beta
0.435
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with ANI Pharmaceuticals Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get ANI Pharmaceuticals Inc data using free add-ons & libraries
Get ANI Pharmaceuticals Inc Fundamental Data
ANI Pharmaceuticals Inc Fundamental data includes:
- Net Revenue: 883 M
- EBITDA: 175 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-02-26
- EPS/Forecast: 2.04
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
ANI Pharmaceuticals Inc News
New
Zacks.com featured highlights include Intuit, ANI Pharmaceuticals and Gaming and Leisure Properties
For Immediate Release Chicago, IL – April 9, 2026 – Stocks in this week’s article are Intuit Inc. INTU, ANI Pharmaceuticals, Inc. ANIP and Gaming and Leisure Properties, Inc. GLPI. 3 Best Earn...
ANI Pharma Launches Isosorbide Mononitrate Tablet Following FDA Approval
(RTTNews) - ANI Pharmaceuticals, Inc. (ANIP), a generic pharmaceutical product manufacturer, announced that following final approval for its Abbreviated New Drug Application (ANDA) from the U.S. Food ...
Is American Well (AMWL) Outperforming Other Medical Stocks This Year?
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is American Well Corporation (AMWL) one of those stocks right no...
Insmed Ends Brinsupri Development in Skin Disease Post Study Failure
Insmed INSM announced that it is discontinuing the development of Brinsupri (brensocatib) for hidradenitis suppurativa (HS) following disappointing mid-stage study results. The decision comes after d...
Get ANI Pharmaceuticals Inc fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
